Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:05:41 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



News for C:MDP from 2023-05-04 to 2024-05-03 - 37 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-05-01 17:47C:MDPMedexus Pharmaceuticals Inc1.75News ReleaseMedexus's Metoject patent no longer in effect in Canada
2024-03-26 12:03C:MDPMedexus Pharmaceuticals Inc1.70News ReleaseMedexus gets Ixinity supplemental biologics licence OK
2024-02-07 19:36C:MDPMedexus Pharmaceuticals Inc2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-07 19:36C:MDPMedexus Pharmaceuticals Inc2.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-07 18:09C:MDPMedexus Pharmaceuticals Inc2.70News ReleaseMedexus loses $500,000 (U.S.) in fiscal Q3 2024
2024-01-30 10:37C:MDPMedexus Pharmaceuticals Inc2.49News ReleaseMedexus to release Q3 2024 results Feb. 7
2024-01-08 10:44C:MDPMedexus Pharmaceuticals Inc2.87News ReleaseMedexus nail lacquer accepted for Health Canada review
2023-11-08 18:40C:MDPMedexus Pharmaceuticals Inc2.05News ReleaseMedexus loses $1.09-million (U.S.) in Q2 fiscal 2024
2023-11-08 07:56C:MDPMedexus Pharmaceuticals Inc2.05SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-08 07:44C:MDPMedexus Pharmaceuticals Inc2.05SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-01 12:27C:MDPMedexus Pharmaceuticals Inc2.03News ReleaseMedexus to release Q2 2024 results Nov. 8
2023-10-17 13:47C:MDPMedexus Pharmaceuticals Inc2.45News ReleaseMedexus completes $1.5M overallotment option
2023-10-16 13:11C:MDPMedexus Pharmaceuticals Inc2.49News ReleaseMedexus Pharmaceuticals repays convertible debentures
2023-10-06 21:01C:MDPMedexus Pharmaceuticals Inc2.79MiscellaneousMedexus 6% debentures to be delisted Oct. 16
2023-10-06 11:06C:MDPMedexus Pharmaceuticals Inc2.74News ReleaseMedexus Pharmaceuticals closes $10M public offering
2023-10-04 19:30C:MDPMedexus Pharmaceuticals Inc3.00Prospectus ApprovedMedexus Pharmaceuticals prospectus offering
2023-09-28 19:45C:MDPMedexus Pharmaceuticals Inc2.96News ReleaseMedexus amends outside date under medac licensing deal
2023-09-21 17:12C:MDPMedexus Pharmaceuticals Inc3.00News ReleaseMedexus shareholders elect seven directors at AGM
2023-09-05 19:05C:MDPMedexus Pharmaceuticals Inc3.13News ReleaseMedexus Pharmaceuticals arranges $10M public offering
2023-09-05 14:56C:MDPMedexus Pharmaceuticals IncSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2023-09-05 14:40C:MDPMedexus Pharmaceuticals Inc3.13News ReleaseMedexus amends credit agreement with BMO
2023-09-05 10:21C:MDPMedexus Pharmaceuticals Inc3.13SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2023-08-17 17:41C:MDPMedexus Pharmaceuticals Inc2.66News ReleaseMedexus presents phase 3/4 study data for Ixinity
2023-08-09 18:47C:MDPMedexus Pharmaceuticals Inc2.93News ReleaseMedexus earns $700,000 (U.S.) in Q1 fiscal 2024
2023-08-09 18:28C:MDPMedexus Pharmaceuticals Inc2.93SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-02 13:51C:MDPMedexus Pharmaceuticals Inc2.17News ReleaseMedexus to release fiscal Q1 results Aug. 9
2023-07-12 17:36C:MDPMedexus Pharmaceuticals Inc1.85News ReleaseMedexus estimates Q1 preliminary revenue at $31M (U.S.)
2023-06-23 07:52C:MDPMedexus Pharmaceuticals Inc1.35In the NewsGlobe says Medexus Pharma raised to "speculative buy"
2023-06-21 18:05C:MDPMedexus Pharmaceuticals Inc1.24SEDAR Annual Information FormSEDAR Annual Information Form
2023-06-21 18:03C:MDPMedexus Pharmaceuticals Inc1.24SEDAR MD & ASEDAR MD & A
2023-06-21 18:02C:MDPMedexus Pharmaceuticals Inc1.24SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-06-21 17:59C:MDPMedexus Pharmaceuticals Inc1.24News ReleaseMedexus earns $1.2-million (U.S.) in fiscal 2023
2023-06-15 10:07C:MDPMedexus Pharmaceuticals Inc1.22News ReleaseMedexus's Ixinity sBLA accepted for FDA review
2023-06-14 18:04C:MDPMedexus Pharmaceuticals Inc1.20News ReleaseMedexus to file fiscal 2023 results June 21
2023-06-13 10:07C:MDPMedexus Pharmaceuticals Inc1.17News ReleaseMedexus cheers new treosulfan data shown at MDS 2023
2023-05-10 20:19C:MDPMedexus Pharmaceuticals Inc1.43News ReleaseMedexus receives TSX OK for buyback of 6% debentures
2023-05-09 21:55C:MDPMedexus Pharmaceuticals IncNews ReleaseMedexus Pharmaceuticals talks cost savings with Gleolan